🔎 Trials Near Me

Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › Nebraska › Omaha

Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) Omaha, NE keessatti

Qorannoo 12 Kansara Harkaa (Karsinomaa Seli Renal) f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Research Site, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • NEO-811 Omaha Site, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07300241

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Namoota walitti qabaa jiraSadarkaa 1
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07419841

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Alegent Health Immanuel Medical Center, Omaha
  • Alegent Health Bergan Mercy Medical Center, Omaha
  • Alegent Health Lakeside Hospital, Omaha
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #2, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Research site, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07688187

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Namoota walitti qabaa jiraSadarkaa 3
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0131), Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT07227402

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT04198766

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Oncology Associates PC, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT04510597

Qorannoo Kansara Harkaa (Karsinomaa Seli Renal) magaalota biroo keessatti

Qorannoo biroo Omaha keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.